Leukemia Research
Volume 26, Issue 8 , Pages 705-711 , August 2002

Relationship between CD4+/CD8+ T cell ratio and T cell activation in multiple myeloma: reference to IL-16

  • Michiaki Koike

      Affiliations

    • Department of Internal Medicine, Juntendo University Izu-Nagaoka Hospital, 1129 Nagaoka, Izu-Nagaoka, Tagata-gun, Shizuoka, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-559-48-3111; fax: +81-559-48-5088
    • ,
  • Iwao Sekigawa

      Affiliations

    • Department of Internal Medicine, Juntendo University Izu-Nagaoka Hospital, 1129 Nagaoka, Izu-Nagaoka, Tagata-gun, Shizuoka, Japan
    • ,
  • Makiko Okada

      Affiliations

    • Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Shizuoka, Japan
    • ,
  • Michio Matsumoto

      Affiliations

    • Department of Pathology, Juntendo University Izu-Nagaoka Hospital, Shizuoka, Japan
    • ,
  • Noboru Iida

      Affiliations

    • Department of Internal Medicine, Juntendo University Izu-Nagaoka Hospital, 1129 Nagaoka, Izu-Nagaoka, Tagata-gun, Shizuoka, Japan
    • ,
  • Hiroshi Hashimoto

      Affiliations

    • Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Shizuoka, Japan
    • ,
  • Kazuo Oshimi

      Affiliations

    • Department of Hematology, Juntendo University School of Medicine, Shizuoka, Japan

Received 16 July 2001 ,Accepted 14 November 2001.

References 

  1. Mellsted H, Holm G, Petterson G, Bjorkholm M, Johansson B, Lindenholm C, et al.  T cells in monoclonal gammopathies. Scand. J. Haematol. 1982;29:57–64
  2. Mills KHG, Cawley JC. Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationships to treatment and clinical stage. Br. J. Haematol. 1983;53:271
  3. San Miguel JF, González M, Gascón A, Moro MJ, Hernández JM, Ortega F, et al.  Lymphoid subsets and prognostic factor in multiple myeloma. Br. J. Haematol. 1992;80:305–309
  4. Dianzani U, Pileri A, Boccadoro N, Palumbo A, Pioppo P, Bianchi A, et al.  Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. Blood. 1988;72:1064–1068
  5. Massaia M, Dianzani U, Bianchi A, Camponi M, Boccadoro M, Pileri A, et al.  Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies. Clin. Exp. Immunol. 1988;73:214–218
  6. Massaia M, Bianchi A, Attisano C, Peol S, Redoglia V, Dianzani U, et al.  Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex. Blood. 1992;78:1770–1780
  7. Center DM, Cruikshank WW. Modulation of lymphocyte migration by human lymphokines. J. Immunol. 1982;128:2563–2568
  8. Cruikshank WW, Center DM. Modulation of lymphocyte migration by human lymphokines: purification of a lymphotactic factor (LCF). J. Immunol. 1982;128:2569–2574
  9. Cruikshank WW, Berman J, Theodore AC, Bernardo J, Center DM. Lymphocyte activation of T4+ T lymphocytes and monocytes. J. Immunol. 1987;138:3817–3825
  10. Parada NA, Cruikshank WW, Danis HL, Ryan TC, Center DM. IL-16 and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell Immunol. 1965;168:100–106
  11. Center DM, Kornfeld H, Cruikshank WW. Interleukin 16 and its function as a CD4 ligand. Immunol. Today. 1996;17:476–480
  12. Theodore C, Center DM, Nicoll J, Fine J, Kornfeld H, Cruikshank WW, et al.  CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J. Immunol. 1996;157:1958–1964
  13. Hishikawa T, Tokano Y, Sekigawa I, Aodo S, Takasaki Y, Hashimoto H, et al.  HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1990;55:285–296
  14. Cruikshank WW, Lim K, Theodore AC, Cook J, Fine G, Weller PF, et al.  IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J. Immunol. 1996;157:5240–5248
  15. Newell MK, Naughn LJ, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature. 1990;347:286–289
  16. Sekigawa I, Koshino K, Hishikawa T, Hashimoto H, Hirose S, Inagaki K. Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120. J. Clin. Immunol. 1995;15:312–317
  17. Ogasawara H, Takeda-Hirokawa N, Sekigawa I, Hashimoto H, Kaneko Y, Hirose S. Inhibitory effect of interleukin-16 on iterleukin-2 by CD4+ T cells. Immunology. 1999;96:215–219
  18. Lee S, Kaneko H, Sekigawa I, Tokano Y, Takasaki Y, Hashimoto H. Circulating interleukin-16 in systemic lupus erythematosus. Br. J. Rheumatol. 1998;96:215–219
  19. Maeda N, Sekigawa I, Iida N, Mastumoto M, Hashimoto H, Hirose S. Relationship between CD4+/CD8 T cell ratio and T cell activation in systemic lupus erythmatosus. Scand. J. Rheumatol. 1999;28:166–170
  20. Suh WK, Cohen-Doyle MF, Fruh K, Wang K, Peterson PA, Williams DB, et al.  Interaction of MHC class I molecules with the transporter associated with antigen processing. Science. 1994;264:1322–1326
  21. Sekigawa I, Matsushita M, Lee S, Maeda N, Ogasawara H, Kaneko H, et al.  A possible pathogenic role of CD8+ T cells and their derived cytokine, IL-16, in SLE. Autoimmunity. 2001;33:37–44
  22. Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Takasaki Y, Hashimoto H, et al.  Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen: with reference to the pathogenesis of systemic lupus erythematosus. Rheumatology. 1999;38:1163–1164
  23. Ogasawara H, Naito T, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, et al.  Quantitative analyses of messenger RNA of human endogenous retrovirus in SLE patient. J. Rheumatol. 2001;28:533–538

PII: S0145-2126(01)00192-8

Leukemia Research
Volume 26, Issue 8 , Pages 705-711 , August 2002

Article Tools

* Image Usage & Resolution